Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals's GHG Emissions Data Preview
In 2025, Torrent Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Torrent Pharmaceuticals has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
a
a
a
a
a
a
a
a
a
aVerified Sources Behind Torrent Pharmaceuticals’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Torrent Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Insights into Torrent Pharmaceuticals's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of Torrent Pharmaceuticals amounted to 87,529 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Torrent Pharmaceuticals decreased by 4.4%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Torrent Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Torrent Pharmaceuticals's Scope 1 emissions?
In 2025, the total Scope 1 emissions of Torrent Pharmaceuticals were 8,937 metric tons of CO₂ equivalent (tCO₂e). a
Has Torrent Pharmaceuticals reduced its Scope 1 emissions over time?
Since 2022, Torrent Pharmaceuticals's Scope 1 emissions have decreased by 68.09%, reflecting a declining long-term trend in Scope 1 emissions over time. a c
Compared to the previous year (2024), Torrent Pharmaceuticals's Scope 1 emissions decreased by 41.57%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Torrent Pharmaceuticals's Scope 2 emissions?
In 2025, Torrent Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 78,592 tCO₂e without specifying the calculation method. a
Has Torrent Pharmaceuticals reduced its Scope 2 emissions over time?
Since 2022, Torrent Pharmaceuticals's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 19.9%, reflecting a declining long-term trend in Scope 2 emissions over time. a c
Compared to the previous year (2024), Torrent Pharmaceuticals's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Torrent Pharmaceuticals 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does Torrent Pharmaceuticals use for Scope 2 reporting?
In 2025, Torrent Pharmaceuticals reported its Scope 2 emissions using an unspecified methodology. a
Torrent Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Torrent Pharmaceuticals's Value Chain Emissions
In 2025, Torrent Pharmaceuticals reported 154,837.27 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2025 disclosure of Torrent Pharmaceuticals includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2024, reflecting improved emissions accounting practices and greater transparency across the company's value chain a
Torrent Pharmaceuticals's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Torrent Pharmaceuticals's Scope 3 emissions?
In 2025, Torrent Pharmaceuticals reported total Scope 3 emissions of 154,837.27 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 99.99% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.01% came from downstream activities like product use, distribution, and end-of-life treatment. a
What categories of Scope 3 emissions does Torrent Pharmaceuticals disclose?
In 2025, Torrent Pharmaceuticals reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Torrent Pharmaceuticals's Scope 3 emissions?
In 2025, the largest contributors to Torrent Pharmaceuticals's Scope 3 emissions were: a
- Purchased Goods and Services (Cat. 1): 67,010.17 tCO₂e (43.28%)
- Fuel- and Energy-Related Services (Cat. 3): 33,932.76 tCO₂e (21.92%)
- Business Travel (Cat. 6): 23,182.71 tCO₂e (14.97%)
Torrent Pharmaceuticals's Scope 3 Emissions by Categories
Insights into Torrent Pharmaceuticals’s GHG Emissions Intensity Compared to Industry Peers
In 2025, Torrent Pharmaceuticals reported Scope 1 greenhouse gas (GHG) emissions of 8,937 tCO₂e and total revenues of USD 1,325 millions. This translates into an emissions intensity of 6.75 tCO₂e per millions USD. a
Torrent Pharmaceuticals's Scope 1 Emissions Intensity Compared to Peers
How does Torrent Pharmaceuticals's GHG emissions intensity compare to its peers?
In 2025, Torrent Pharmaceuticals reported a Scope 1 emissions intensity of 6.75 tCO₂e per millions USD. Compared to the peer group median of 28.64 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Torrent Pharmaceuticals rank on GHG emissions intensity within its industry?
In 2025, Torrent Pharmaceuticals ranked 3 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Torrent Pharmaceuticals among the top performers, with one of the lowest emissions intensities relative to peers. a
Insights into Torrent Pharmaceuticals's Total Carbon Footprint
In 2025, Torrent Pharmaceuticals reported a total carbon footprint of 242,366.27 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 164.7% increase compared to 2024, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Torrent Pharmaceuticals's total carbon footprint was Scope 3 emissions, accounting for 63.89% of the company's total carbon footprint, followed by Scope 2 emissions at 32.43%. a